Press release
Actelion Places Order with Werum for an MES for Weighing and Warehouse Management
Actelion Ltd is a biopharmaceutical company headquartered in Allschwil/Basel Switzerland. Founded in 1997, the company is meanwhile a leading player in innovative science related to the endothelium. The endothelium is the single layer of cells separating every blood vessel from the blood stream. Actelion focuses on the discovery, development and marketing of innovative drugs for significant unmet medical needs.
Werum Software & Systems, Tel. USA +1 (973) 644-4000, Tel. Europe +49 (0)4131 8900-0, Press Contact: Volker Mensing, mensing@werum.com
About Werum
Werum Software & Systems (www.werum.com) is a leading supplier of Manufacturing Execution Systems for the pharmaceutical and biopharmaceutical industry worldwide. Twelve of the world's top 20 pharmaceutical companies use Werum's product suite PAS-X to run their manufacturing business. Outstanding PAS-X features are the functions ensuring compliance and boosting performance. The modular system suite includes components for Production Planning and Scheduling, Master Batch Record Management, Electronic Batch Recording, Weighing and Dispensing, Material Flow Control and Tracking, Equipment Integration, Warehouse Management, Quality Management, and Performance Management based on KPI Analysis. Werum’s solutions and services range from software consulting, creation of functional specifications, and software development to turn-key delivery of integrated and validated Manufacturing Execution Systems. Founded in 1969, the IT company employs more than 290 people in its headquarters in Lueneburg, Northern Germany, the regional offices in West and Southwest Germany, and the subsidiary in Parsippany, New Jersey, USA.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actelion Places Order with Werum for an MES for Weighing and Warehouse Management here
News-ID: 28059 • Views: …
More Releases from Werum Software & Systems
13th PAS-X User Group Meeting in Germany
13th PAS-X User Group Meeting in Germany
Werum Manufacturing IT Conference with record attendance
Lueneburg, Germany, 26 October 2011 – The 13th international PAS-X User Group Meeting took place from 13 to 14 October 2011 in Lueneburg, Germany, with a record attendance. On the invitation of Werum Software & Systems AG, almost 200 pharmaceuticals experts from approximately 20 countries exchanged their thoughts and ideas on the use of the PAS-X production management…
Indian pharmaceutical major Dr. Reddy's chooses to implement Werum's MES
Dr. Reddy's Laboratories Ltd. deploys PAS-X at Hyderabad site
Lueneburg, Germany, August 20, 2010 – Dr. Reddy's Laboratories Ltd. has decided to introduce PAS-X, the Manufacturing Execution System (MES) by Werum Software & Systems, at its site in Bachupally, Hyderabad.
Dr. Reddy's plans to optimize the efficiency, quality, compliance and performance of its production processes with PAS-X. Werum is the leading supplier of MES systems for the pharmaceutical and biopharmaceutical industries…
MSD Packaging Lines run with PAS-X
Lueneburg, Germany, August 17, 2010 - MSD deployed PAS-X, the Manufacturing Execution System (MES) by Werum Software & Systems, to run its packaging line operations in Heist-op-den-Berg, Belgium in order to increase the compliance level during packaging operations and subsequently shorten lead times to improve delivery performance. Operations include fully automated blister lines and filling lines, semi-automated packaging lines and manual packaging processes. The project for introducing PAS-X was completed…
Successful rollout of PAS-X MES Weighing & Dispensing at AstraZeneca in India an …
Manufacturing Execution System projects completed successfully
Lueneburg, Germany, March 25, 2010 - Manufacturing Execution System (MES) software provider Werum Software & Systems has successfully finalized the installation of PAS-X MES in AstraZeneca's Wuxi site in the Jiangsu Province, China. This first-time MES project in the Chinese pharmaceutical industry follows an employment of Werum's PAS-X MES software in AstraZeneca's Indian production site in Bengaluru (formerly Bangalore) in 2009.
Both MES projects are part…
More Releases for Actelion
Pulmonary Arterial Hypertension Market Analysis: Strategic Insights from Gilead, …
The Global Pulmonary Arterial Hypertension Market size was worth USD 7 billion in 2022 and is estimated to reach USD 10.6 billion by 2031, growing at a CAGR of 5.3% during the forecast period 2024-2031.
Pulmonary Arterial Hypertension Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
Iloprost Drugs Market Size, Share, And Opportunities to 2033 Bayer, Actelion
Iloprost is a synthetic analog of prostacyclin (PGI2) used to manage conditions such as pulmonary arterial hypertension (PAH) and peripheral arterial disease. Unlike natural prostacyclin, it is more chemically stable, allowing for longer therapeutic effects. Administered via inhalation or intravenous infusion, iloprost works as a vasodilator, inhibiting platelet aggregation and reducing vascular resistance. Its inhalation route is particularly advantageous, delivering localized pulmonary effects with minimal systemic exposure, thereby reducing side…
Plague Therapeutics Market | Abbott, Achaogen, Actelion Pharmaceuticals, Allerga …
The global plague therapeutics market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the plague therapeutics market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Hypertension Drugs Market 2021 Projection By Key players – Novartis, Daiichi S …
Hypertension Drugs Market 2021 – 2027
New Study Reports “Hypertension Drugs Market 2021 Global Market Opportunities, Challenges, Strategies and Forecasts 2027″ has been Added on ResearchNReports.
Summary:
The report analyses the global Hypertension Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth…
What's Driving the Antidiarrheals Market Growth? Actelion,Lupin,GSK
The Global Antidiarrheals Market analysis report published on Upmarketresearch.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.
Get FREE Exclusive PDF Sample Copy of This Report: https://www.upmarketresearch.com/home/requested_sample/44191
The…
Global Gaucher Disease Market- Pfizer, Sanofi, Actelion Pharma, Shire
Global Gaucher Disease Market report 2017 is an in-depth research on the current situation of the Gaucher Disease industry.
The Scope of the Gaucher Disease research report:
The Global Gaucher Disease Market primarily includes a basic overview of the Gaucher Disease industry. It also includes Gaucher Disease definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Gaucher Disease market size, business share and Gaucher…
